What Is Fennec Pharmaceuticals Inc. (FENC) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Fennec Pharmaceuticals Inc.'s intrinsic value is estimated at $6.30. Trading at its current price of $10.75, the valuation engine raises significant caution: 8 of 10 models flag downside risk, projecting an average implied return of -41.4%. Model dispersion is worth noting: RCMH-DCF targets $13.40 (+24.7%), versus ML-RIV at $0.09 (-99.1%). This +123.8% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About FENC?
10 of 13 models are currently active for FENC. Of these, 2 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates FENC's intrinsic value at $11.32, implying +5.3% upside from the current price. See which stocks rank higher →
How Does FENC Rank in Biological Products, (No Diagnostic Substances)?
Among 139 Biological Products, (No Diagnostic Substances) stocks, FENC ranks #20 by Quality of Company score. CirclFi's QOC score of 6.8/10 evaluates 32 fundamental signals. A score of 6.8 indicates above-average quality.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Fennec Pharmaceuticals Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is FENC a Value Trap?
CirclFi's Value Trap algorithm assigns FENC a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
10 of 13 models are active for Fennec Pharmaceuticals Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Fennec Pharmaceuticals Inc. earns a quality score of 6.8/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +123.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every FENC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across FENC's 10 active models, average confidence is 27%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad